Your browser doesn't support javascript.
loading
Combined use of nivolumab and ipilimumab in Japanese patients with melanoma: a multicentre retrospective study of 111 cases.
Fujisawa, Yasuhiro; Namikawa, Kenjiro; Yoshino, Koji; Kiniwa, Yukiko; Ito, Takamichi; Kato, Hiroshi; Matsushita, Shigeto; Hoashi, Toshihiko; Nakamura, Yasuhiro; Yoshikawa, Shusuke; Miyagawa, Takuya; Asai, Jun; Matsuya, Taisuke; Fukushima, Satoshi; Kato, Jyunji; Takenouchi, Tatsuya; Uchi, Hiroshi; Masuzawa, Mamiko; Yanagi, Teruki; Maekawa, Takeo.
Affiliation
  • Fujisawa Y; Department of Dermatology, University of Tsukuba, Tsukuba.
  • Namikawa K; Department of Dermatology, Ehime University, To-on.
  • Yoshino K; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo.
  • Kiniwa Y; Dermatologic Oncology/Dermatology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo.
  • Ito T; Department of Dermatology, Shinshu University, Matsumoto.
  • Kato H; Department of Dermatology, Kyushu University, Fukuoka.
  • Matsushita S; Department of Geriatric and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya.
  • Hoashi T; Department of Dermato-Oncology/Dermatology, National Hospital Organization Kagoshima Medical Center, Kagoshima, Japan.
Br J Dermatol ; 189(2): 223-250, 2023 07 17.
Article in En | MEDLINE | ID: mdl-37017027

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Br J Dermatol Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Br J Dermatol Year: 2023 Document type: Article